Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 9Recruiting 4Terminated 3Active not recruiting 3Unknown 2Not yet recruiting 2

Sponsor Class

OTHER 1FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Leiomyoma 1

Interventions

Cisplatin 512Radiotherapy 376Cyclophosphamide 361Carboplatin 354Capecitabine 341Oxaliplatin 331Paclitaxel 328Gemcitabine 318Docetaxel 314Fluorouracil 288Drug Therapy 271apatinib 245Bevacizumab 243camrelizumab 217Etoposide 200Irinotecan 182Doxorubicin 180Leucovorin 160Dexamethasone 160pembrolizumab 150sintilimab 143Neoadjuvant Therapy 142anlotinib 139Pemetrexed 138Cytarabine 138Blood Specimen Collection 138Surgical Procedures, Operative 130toripalimab 128Radiosurgery 127S 1 (combination) 124

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Hysterectomy × Clear all
NCT02422563 2015-04-21

NACOPRAD

Charite University, Berlin, Germany

Phase 3 Unknown
534 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00390494 2008-06-30

Questionnaire Study to Assess Quality of Life After Treatment of Fibroids

Walter Reed Army Medical Center

Unknown
400 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡